View Author
scopus: 14014266800

Staa, T. van

(Tjeerd Staa)


fracture risk factors study antipsychotic factor women cohort hip /femur fracture hip fracture fracture risk osteoporosis osteoporotic fractures osteoporotic osteoporo medium bone mineral density patient prediction gradient model effect /femur laet c index date femoral neck risk score hip fracture prediction validation cohorts table score antipsychotic use density analysis femoral femoral neck bmd history property individual osteoporotic fracture information follow-up university population johnell control performance characteristics miner index european treatment johansson h oradj assessment reeve j health disease mineral research centre validation 50 years risk factor 182 days baseline antipsychotic drugs follow-up time characteristic hip fracture risk gothenburg group 70 years performance roc curve geelong osteoporosis study participant johansson association curve value




2 Most Recent Publications

Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study (Article)
Pouwels, S. Lalmohamed, A. Souverein, P. Cooper, C. Veldt, B.J. Leufkens, H.G.M. Boer, A. de Staa, T. van Vries, F. de
2010-01-01
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women (Article)
Kanis, J.A. Oden, A. Eisman, J.A. Fujiwara, S. Glüer, C. Goltzman, D. Hans, D. Krieg, M.-A. La Croix, A. McCloskey, E. Mellström, D. Melton III, L.J. Johnell, O. Pols, H.A.P. Reeve, J. Sanders, K. Schott, A.-M. Silman, A.J. Torgerson, D. Staa, T. van Watts, N.B. Yoshimura, N. Johansson, H. Laet, C.E.D. de Brown, J. Burckhardt, P. Cooper, C. Christiansen, C. Cummings, S.
2007-08-01